Pre-earnings brief
Reports
Wed, Oct 28, 2026
Est. EPS
$2.78
Est. revenue
$1.0B
Implied move
±12.0%
EPS beat rate
100%
Align Technology, Inc. (ALGN) is a leader in the healthcare sector, specializing in innovative dental products, particularly clear aligners. With a market cap of $10 billion, the company plays a significant role in the growing demand for orthodontic solutions and digital dentistry.
Last quarter
In Q2 2026, Align reported an EPS of $2.64, significantly beating expectations of $2.08, which led to a positive market reaction. However, revenue figures were not disclosed, leaving some uncertainty.
Management promises and guidance
EPS beat streak
8Q
EPS beat rate
100%
Avg EPS surprise
+31.73%
Avg 1-day reaction
+0.08%
Analysts are generally optimistic about Align's upcoming earnings, expecting continued growth in EPS and revenue. The company has a strong track record of beating earnings estimates.
Bull case
If Align continues its trend of exceeding EPS estimates, it could indicate strong operational efficiency and market demand, potentially driving the stock higher.
Bear case
Conversely, if the company fails to meet revenue expectations or provides cautious guidance, it could lead to a negative market reaction, especially given the high implied volatility.
Key metrics to watch
EPS
$2.78Earnings per share is a key indicator of profitability and helps gauge the company's financial health.
Revenue
$1.0BRevenue figures provide insight into the overall sales performance and market demand for Align's products.
The print will turn on these.
Q1
Will Align's EPS exceed the consensus estimate of $2.78?
A beat on EPS could reinforce investor confidence and lead to a positive stock reaction.
Q2
What guidance will Align provide for revenue growth in the upcoming quarters?
Clear guidance on revenue will help investors assess the company's growth trajectory and market demand.
—
Est. EPS
—
Est. Rev
—
Impl. Move
±10.3%
Why consensus could be wrong
The consensus may underestimate Align's ability to capitalize on the growing demand for clear aligners, especially in international markets.
Supporting evidence
Align has consistently beaten EPS estimates, indicating strong operational execution.
The implied move of 13.8% suggests that the market is pricing in significant volatility, which may not materialize if results are strong.
Recent trends in orthodontic treatments show increasing consumer interest, which could drive higher-than-expected revenue.
Key risk
If Align's revenue growth exceeds $1.0B, it could challenge the current market expectations.
Pre-commit to what would confirm each case.
The market is closely watching Align's ability to maintain its growth momentum in a competitive landscape.
Bull confirmed if
An EPS of $2.80 or higher would confirm strong operational performance and growth potential.
Bear confirmed if
An EPS below $2.67, combined with weak revenue guidance, would signal potential challenges ahead.
What the market is pricing for the move.
Implied Move
±13.8%
Historical Avg
±1.6%
The options market is pricing in a significant move around the earnings report, suggesting heightened uncertainty or anticipation among investors.
Options are pricing ±12.0% while ALGN has averaged ±1.6% over the last 8 prints — setup is pricing rich.
ATM IV
0.6%
30d HV
29.3%
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options rich in Health Care
Fade rate: 11 of 30 (37%)
This setup has occurred 30 times across Health Care in the last 2 years. 19 of 30 (63%) held or extended their move within 5 days — this setup typically holds direction. The average absolute 1-day move is 3.7%, with a raw directional average of -0.1% (roughly flat historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
105.29%
of float
Insider
6.13%
of float
Holders
960
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
4,419,366 sh · $618.1M
6.17%
3.0%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Align beats expectations, history suggests a potential stock increase of around +0.08%, confirming the company's strong performance.
In line / cautious
If results are in line but management's commentary is cautious, the stock may react neutrally, reflecting uncertainty.
Miss
A miss on EPS could lead to a decline, with historical patterns indicating an average drop of around -2.50%.
The lines on the call that would change the story.
Vanguard Capital Management LLC
4,401,313 sh · $615.6M
6.15%
0.3%
FMR, LLC
4,060,032 sh · $567.9M
5.67%
50.3%
Capital International Investors
4,045,561 sh · $565.9M
5.65%
6.2%
Capital World Investors
3,422,385 sh · $478.7M
4.78%
-16.0%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.